PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (Paris:STNT) (FR0010949404 — STNT – PEA PME eligible), a medical technology company commercializing the world’s first and only Self-Apposing® coronary stent, today reported its financial results for the year to December 31, 2014, approved by the Board of Directors on March 26, 2015. Audit procedures relative to the consolidated accounts have been carried out and the auditor’s report is currently under finalization.
Help employers find you! Check out all the jobs and post your resume.
